Outcome of Implant-supported Overdentures (NCT03777748) | Clinical Trial Compass
UnknownNot Applicable
Outcome of Implant-supported Overdentures
10 participantsStarted 2013-06-01
Plain-language summary
The aim of this pilot study was to assess survival rates and peri-implant bone loss of two narrow-diameter titanium-zirconium implants supporting maxillary and mandibular overdentures during an observation time of 3 years. The masticatory performance, self-reported chewing ability and change of oral health impact profile (OHIP) after rehabilitation were also investigated.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Female and male subjects older than 18 years.
* Edentulous patients with a bone atrophy, which necessitates the use of diameter-reduced implants and excessive augmentation procedures are denied by the patient.
* Sufficient bone supply with minimal risk of injury to neighboring structures when using two 10 mm or longer implants per jaw.
* Bone height above the N. alveolaris inferior of at least 11 mm and the precondition of a one-stage implantation and augmentation.
* Good health condition according to the Physical Status Classification System one or two (American Society of Anesthesiologists, ASA 2010)
* Good oral hygiene and an at most moderate tobacco consumption
* Signed informed consent
Exclusion Criteria:
* Indication for large augmentations of the jaw bone
* Allergy to metallic implant components or prosthesis plastics
* Bisphosphonate therapy
* Chemo-, immuno-, or radiation therapy
* Psychological disorder
* Substance abuse
* Pregnant woman
* Persons who are placed in an institution on a judicial or administrative order
* Any other circumstances that prevent the use of oral surgery
What they're measuring
1
Investigation of the success rates of the implants